⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Quentin LoydMD

Internal Medicine · Miami, FL 33136

NPI: 1639639099

Share:

34

🟠 Elevated

🤖 ML Fraud Detection Score: 86%

Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.

Learn more →

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingElevated long-acting opioid rate

Risk indicators are statistical patterns, not allegations. Learn more

724

Total Claims

$23K

Drug Cost

46

Beneficiaries

$510

Cost/Patient

Risk Score Breakdown 34/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+5
Long-acting opioid rate+4

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+1492%

Opioid rate vs peers

35.6% vs 2.2% avg

-64%

Cost per patient vs peers

$510 vs $1,411 avg

-84%

Brand preference vs peers

1.7% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

🤖

ML fraud detection score of 86% indicates prescribing patterns with significant similarity to confirmed fraud cases. 17 out of 20 decision trees flagged this provider.

⚠️

Opioid prescribing rate is 1,492% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

35.6%

Opioid Rate

258

Opioid Claims

$12K

Opioid Cost

15.9%

Long-Acting Rate

This provider's opioid prescribing rate of 35.6% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

98% generic

Brand: 12 claims · $4,433

Generic: 712 claims · $19K

Patient Profile

63

Avg Age

50%

Female

2.14

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About